Advisory Boards

The Arts & Sciences Advisory Board

Sheryl Atkinson ’83 embarked on a 15-year career with Sikorsky Aircraft following completion of her Bachelor of Science degree in mechanical engineering at WPI and her Master of Science degree at RPI becoming project manager of International Programs before retiring to devote more time to her son, John Jr., and daughter Caroline. Ms. Atkinson’s family connection to WPI runs deep: she met her husband, John ’83 at WPI; her father-in-law, Colonel Paul G. Atkinson Jr., graduated from WPI in 1943; her brother-in-law, Paul Atkinson, graduated in 1982; and his wife, Gay, graduated in 1983. In 2008, Ms. Atkinson and her husband established the Tara K. Bean/Life Sciences Scholarship Fund to honor the memory of the daughter of friend and former WPI Trustee Karen Bean ’86.

Douglas Borden III ’96 is Lead Associate with Booz Allen Hamilton, the leading provider of management and technology consulting services to major corporations and the US Government in such areas as cyber security, international development and diplomacy, engineering, healthcare, infrastructure, and defense. Prior to joining Booz Allen Hamilton, Mr. Borden was a program manager for STG International and for InfoPro, Inc., where he was also a senior researcher. Mr. Borden received his Bachelor of Science degree in engineering physics from Wentworth Institute of Technology and a Master of Mathematics for Education degree from WPI. He served honorably as an officer in the US Coast Guard and previously served as a member of the WPI Provost’s Global Task Force.

Steven Davi ’85 is Senior Vice President at Synacor, Inc. which provides a technology platform to telecom companies that allows end-users to receive digital entertainment services and apps. He was formerly Senior Vice President of Advanced Technology and CTO at SeaChange International, a global multi-screen video software company. Steve received an Emmy for his work in video software while at SeaChange. He earned his Bachelor of Science degree in Computer Science from WPI and his Master of Science degree in Computer Science from Northeastern University. Mr. Davi previously served as a member of the WPI Provost’s Global Task Force.

John Gabranski ’75 is a private consultant who provides guidance to clients in the areas of financial analysis, accounting, and contracting, internal controls, external reporting, and financial integrity. Mr. Gabranski recently retired from PricewaterhouseCoopers, where he was an Assurance Partner. John led the Hartford office assurance practice as well as served clients including Yale, UMass Memorial Health Care, and WPI. He graduated from WPI with a degree in computer science and went on to complete his MBA at the Columbia Business School. Mr. Gabranski joined legacy Coopers & Lybrand in 1978 and was admitted to the partnership in 1985. A CPA and member of the American Institute of Certified Public Accountants (AICPA), John is also a member of the Massachusetts Society of Certified Public Accountants. With his sister, Mr. Gabranski established the Adam and Agnes Gabranski Memorial Scholarship Fund in 1990; the Fund has assisted WPI to attract and graduate bright, promising students ever since.

Leslie Jelalian is the Vice President and General Manager of Engineering, BAE Systems. Ms. Jelalian joined BAE Systems in 1988 (then Sanders). She brings experience in a wide variety of leadership roles in Engineering, Program Management, and Strategy Development as well as experience in the range of program process from technology development and proposals through transition to production. Ms. Jelalian received her Bachelor and Master of Science Degree in Electrical Engineering from University of Massachusetts at Amherst and her Master of Science Degree in Systems Engineering from The Johns Hopkins University. She has received numerous awards including the Association of Old Crows Technology Hall of Fame Award, the University Of Massachusetts College Of Engineering Duane E. Cromack Young Alumni Award, the New England Council's Leadership Award to Women in Business, Nashua YWCA Leadership Award, and the University of Massachusetts Women in Engineering Outstanding Alumna award.

David Johnson ’82 is CEO and President of Jenne Distributors, a leading value-added distributor of business telephony, data, audio and video conferencing, and security technology products, including equipment and software for the SMB and Enterprise markets. He previously held many senior executive positions at Avaya, with his most recent role as Senior Vice President of Global Alliances and Channel. Before his work with Avaya, Mr. Johnson was Senior Vice President, International Sales and Service for Lucent Technologies' Enterprise Networks business, where he was responsible for all sales and service operations outside the United States. Mr. Johnson also served as Lucent's Business Communications Systems (BCS) Regional President for the Asia/Pacific region, residing in Hong Kong for three years. Before his assignment in Hong Kong, Mr. Johnson was Strategic Marketing Director for BCS. Mr. Johnson began his communications career in 1982 with New England Telephone, where he worked in the Field Services Organization supporting business customers. Mr. Johnson earned his bachelor's degree in Engineering from WPI in 1982.

Earl Jones is a Principal with Liberation Capital International, a private equity fund with a focus on renewable energy and waste/wastewater solutions. Prior to joining LCI, Mr. Jones was Global Commercial Leader for GE Water and Process Technologies, responsible for sales, partnerships, risk, and project development. Mr. Jones led the eHealth Solutions business for GE Healthcare IT. A submarine officer who served honorably in the US Navy, Mr. Jones received his undergraduate degree in Electrical Engineering from the US Naval Academy and his Master of Science degree in EE/CS and an MBA from MIT.

Kenneth Kicia ’90 is the Vice President of Portfolio Management at SAIC, a Fortune 500 scientific, engineering, and technology applications company. As the Director of Portfolio Management, he is responsible to manage the corporate program, project and service portfolios and lead yearly planning efforts for the overall IT enterprise project submissions. Previously, Mr. Kicia was the Vice President of IT Service Management at SAIC, responsible to represent IT capabilities in all technology areas related to Business Development, Contracts, Procurement, and other Corporate Services. Before joining SAIC, Ken was a Director at BearingPoint. He then served as Vice President of Sales and Marketing for SkyTECH Solutions, an IT services firm that provides offshore outsourced solutions and services. Mr. Kicia served in the U.S. Navy for eight years as a submarine officer and assistant branch head for Naval Nuclear Reactors. He holds a BS in Electrical Engineering from Worcester Polytechnic Institute, a Master's degree in Industrial & Systems Engineering from Virginia Tech, a Nuclear Engineering certification from the US Navy, and a Professional Engineer’s license from the state of New Jersey.

Marilyn Pifer, PhD is associate program director of the Centers, Institution Building and Innovation at CRDF Global, where she leads higher education programs in Russia (Basic Research and Higher Education, BRHE) and in the Ukraine (Cooperation in Research and Education in Science and Technology, CREST). In 2006, she served as the education expert on a National Research Council committee studying the scientific status and potential of Kazakhstan. Prior to her beginning her work with CRDF Global in 2001, Dr. Pifer served in the US Department of State’s Bureau of Oceans and International Envrionmental and Scientific Affairs with responsibilities involving cooperation in Russia, South Asia and the Middle East. She holds BS and MS degrees in Biology from Stanford University and a PhD in Molecular Biology and Genetics from The John Hopkins University Medical School. Dr. Pifer previously served as a member of the WPI Provost’s Global Task Force.

Leonard Redon ’73 is Deputy Mayor of the City of Rochester, NY and the retired Vice President of Western Operations for Paychex, Inc., a recognized leader in payroll and human resources services and winner of Computerworld’s 100 Best Places to Work in IT. The Deputy Mayor joined Paychex after a 28-year career at Eastman Kodak. He serves on the Boards of the Finger Lakes Health System Agency, the George Eastman House Museum of Photography and Film and the Monroe Community College Foundation. Well known for serving to advance traditionally under-represented youth, he has served on many other local boards including the Center for Youth Services, the Otetiana Council Boy Scouts and the Hochstein School of Music and Dance. A former member of the WPI Board of Trustees, Deputy Mayor Redon received his Bachelor of Science degree in Chemical Engineering.

Eliza Jane Reilly is Director of the Phillips Museum of Art and Visiting Assistant Professor of American Studies at Franklin & Marshall College. Previously she was director of programs in the Office of Science, Health, and Student Engagement at AAC&U. From 1998 to 2003 she also served as the executive director of the American Conference of Academic Deans, a national organization of chief academic officers and other academic administrators committed to improving undergraduate liberal education. Dr. Reilly received an MA in art history and a PhD in American history from Rutgers University and is a Senior Associate with the Science Education for New Civic Engagements and Responsibilities (SENCER) project of AAC&U. For SENCER, Dr. Reilly is the general editor and coordinator of the SENCER Models series.

Sergio Salvatore ’02 (Chair) is Director of E-commerce Services for Barnes & Noble, Inc. An accomplished jazz pianist who recorded two albums by the time he was thirteen, Mr. Salvatore is an entertainment and information industry executive who has loaned his musical talents to WPI for past events. Mr. Salvatore was lead architect of a start-up while still at WPI; upon graduating, he joined Sony Music’s Mobile Technology efforts, moving to Direct-2-Consumer engineering, and then moved rapidly to a senior executive position.

Naveen Selvadurai ’02 is Co-founder, Director and Advisor of Foursquare Labs, Inc. He stepped down from day to day operations on March 4, 2012 and did not elaborate on his plans for the future. At the time he said, “I’m not sure about my exact next steps, but I’ll probably get back to what I love most — being an entrepreneur, learning and building new things.” Founded in 2008, Foursquare is a venture funded smart telephone applications company. Foursquare is estimated to be valued at over $700 million and has 100 plus employees in New-York City, San Francisco and, London. The company’s product is a social network friend-finder, social city guide and a game that challenges users to experience new things, and rewards them for doing so. Concurrently he is also a mentor for the Nike+ Accelerator program. The program aims to leverage the success of the Nike+ platform to support digital innovation by connecting with companies that share Nike’s commitment to help people live more active lives. He has also been an Adjunct Professor at The Cooper Union for the Advancement of Science and Art since 2009. Prior to founding Foursquare, he was Lead Architect and VP of Engineering at Socialite located in New York, NY. Founded in 2005, Socialight is a location-based social media platform for smart phone and web based applications. Previously he was a Senior Software Architect with the Global Digital Business group at Sony Music Entertainment. In this role, he oversaw and developed various applications that dealt with content management and distribution of mobile products and was the lead developer of Sony's Music Box mobile application. Before Sony, he consulted for New York-based Run Tones which was later acquired by Sony in 2002 and enjoyed software engineering stints at Sun Microsystems and Lucent Technologies.

Paul Varadian ’75 is the founder and CEO of ebook451. Ebook451 allows authors to create a social community around their books that engages readers both visually and interactively. Mr. Varadian is also the co-founder of EmpowermentRX, a free internet broadcasting platform available for anyone to use. In addition, he has served as a Partner with the European destination management company Access Adventures. This company has strong ties to the Olympic Movement including securing contracts with 2500 hotels for the 2018 Sochi Winter Olympic Games. Mr. Varadian has also served as an International Representative at the Armenian Olympic Committee for 18 years and was a participant on the USA Bobsled and Skeleton teams from 1984-1990. Mr. Varadian earned his bachelor’s degree in Engineering from WPI in 1975.

Kristen Deming Wheeler ’93 currently manages the enforcement activities and golf ball patent development for the Acushnet Company, a Fairhaven, Massachusetts manufacturer of golf equipment, shoes and apparel. Prior to her current assignment with Acushnet she managed the golf club patent portfolio for over 5 years, working with the Carlsbad, California office and working extensively with the R&D organization. Kristin joined the Acushnet Company in 2004 after 4 years at the Boston IP specialty law firm Wolf Greenfield PC. Kristin’s principle work was writing and prosecuting patent applications and clearing new products across several industries including kitchen products, medical devices and sporting goods. Kristin started her legal career at Pennie and Edmonds’ Washington, D.C. office working with clients on patent prosecution, clearances and litigation. Kristin has a BS degree in mechanical engineering from WPI as well as a JD from Franklin Pierce Law Center, which has recently merged into the University of New Hampshire system. Kristin also holds a LL.M. in Intellectual Property Law from Franklin Pierce. Kristin is admitted to practice in the Commonwealth of Virginia and to practice before the US Patent and Trademark Office as well as various federal and state courts.

The Life Sciences & Bioengineering Center Advisory Board

Craig C. Mello, PhD (Chair) is the Blais University Chair in Molecular Medicine and co-director of the RNA Therapeutics Institute at the University of Massachusetts Medical School (UMMS) in Worcester, Massachusetts. He was also designated an Investigator of the Howard Hughes Medical Institute in 2000, the third HHMI researcher selected at UMMS. HHMI is a $13 billion medical research organization that employs more than 350 eminent researchers at 72 medical schools, universities and research institutes worldwide. Dr. Mello and his colleague Andrew Fire, PhD, of Stanford University, received the 2006 Nobel Prize in Physiology or Medicine for their discoveries related to RNA interference (RNAi).
Dr. Mello holds his BS in biochemistry from Brown University and his PhD in Cellular and Developmental Biology from Harvard University. He was a postdoctoral fellow at the Fred Hutchinson Cancer Research Center before coming to UMMS in 1994. He was also a 1995 Pew Scholar in the Biomedical Sciences. Dr. Mello and Dr. Fire, formerly of the Carnegie Institution of Washington, demonstrated that a certain form of RNA had the unanticipated property of silencing—or interfering with—the expression of a gene whose coding sequence of DNA was similar to that of the RNA they tested. The RNAi mechanism—a natural response of an organism to double-stranded RNA, of which many viruses are comprised—destroys the gene products that a virus needs to replicate itself, essentially halting the progression of the invading viral infection.

William C. Alexander’81 began his manufacturing career in 1981, joining Pfizer at the Groton Ct manufacturing facility. While there, he held a variety of manufacturing positions, in process , production, and automation management. Bill was responsible for all automation activities in the Groton plant prior to being appointed to the role of Production Services Manager in 1992. Based in New York he provided technical and project support to the US plant network. In 1996 Bill moved into supply chain planning and in 1998 he was appointed Team Leader, Drug Substance Planning. Iin 2000, he was named Director/Team Leader, Global Drug Substance Supply, responsible for all Drug Substance planning and capacity management for Pfizer’s DS network. In 2002, he moved to the Brooklyn plant as the Director of Packaging. In May of 2006 Bill moved back to the NY office as part of the External Supply Manufacturing team. In February of 2009 he was appointed to Sr. Director/Team Leader in Global External Supply responsible for New Products and Portfolio Management of the external supply network. In December of 2012 he moved into his current assignment as a Sr. Director, in Business Development. Bill holds a B.S. in Chemical Engineering from Worcester Polytechnic Institute, an M.B.A. from Rensselaer Polytechnic Institute and an M.S. in Computer Science from Rensselaer Polytechnic Institute.

Marni Hall serves as Director of Regulatory Science, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration. In this role, Dr. Hall leads post-market drug safety activities focused on adverse event signal detection and characterization. Dr. Hall leads pharmacoepidemiology research programs, pharmacovigilance innovative tool development efforts, and regulatory science policy initiatives to support post-market drug safety. Prior to being selected as Director of Regulatory Science, Dr. Hall served as Program Director for Regulatory Research in the Office of Surveillance and Epidemiology, and as Senior Analyst conducting strategic planning for translational sciences and for data standards in the Office of Planning and Informatics. Before joining FDA in 2008, Dr. Hall was a Program Director at Pfizer, in the Public Health Group of External Medical Affairs. Dr. Hall continues to lecture at Columbia University’s Mailman School of Public Health, where she has been an adjunct professor since 2007. Dr. Hall holds a bachelor’s degree in chemistry and in society, technology, and policy from Worcester Polytechnic Institute, a master’s of public health from Columbia University’s Mailman School of Public Health, and a master’s in biochemistry and PhD in toxicology from Columbia University’s Graduate School of Arts and Sciences

Peter C. Isakson, Ph.D. is the Immunology Research Divisional Vice President and Site Head of the Abbott Bioresearch Center, Global Pharmaceutical Research and Development, located in Worcester. Dr. Isakson is responsible for the oversight and strategic development of Abbott's Immunology and Biologics research program. Prior to joining Abbott, Isakson served in a number of positions of increasing responsibility at Searle/Pharmacia, from 1991 to 2003; his final position at Pharmacia was Vice President, R&D Strategy. While at Searle/Pharmacia he played a key role in the discovery and development of Celebrex, the first selective COX-2 inhibitor approved for treatment of the signs and symptoms of arthritis. He has extensive experience in experimental and applied pharmacology and immunology. Dr. Isakson received a Bachelor of Science degree from Weber State College in 1972 and a Ph.D. in Pharmacology from Washington University in 1976 under the direction of Dr. Philip Needleman. Post-doctoral work was done at Southwestern Medical School in Dallas with Drs. Jon Uhr and Ellen Vitetta. Dr. Isakson has published over 120 peer-reviewed articles and numerous book chapters. He is currently on the Board of Directors of MassBio, and the Scientific Advisory Councils for the Life Sciences at WPI and the Center for Drug Discovery at Northeastern University.

Deborah T. Kochevar, DVM, PhD is the Henry and Lois Foster Professor and Dean of the Cummings School of Veterinary Medicine at Tufts University in North Grafton, MA. Dr. Kochevar was graduated Phi Beta Kappa with a Bachelor of Arts degree in English and biology from Rice University in 1978. She received a Doctor of Veterinary Medicine degree from Texas A&M University in 1981, and a PhD degree in cellular and molecular biology from the University of Texas Southwestern Medical Center in 1987. She was a National Institutes of Health National Research Service Award Fellow from 1984-86. In the mid-1990s, she spent a year in Washington, DC, as a Congressional Science Fellow to the Senate Labor and Human Resources Committee. Dr. Kochevar is a past president of the American College of Veterinary Clinical Pharmacology and is active in the American Veterinary Medical Association (AVMA), having chaired its Council on Education and the Educational Commission for Foreign Veterinary Graduates. She currently serves as secretary and member of the Board of Directors, Association of American Veterinary Medical Colleges. Dr. Kochevar has won many teaching awards, including the Norden Distinguished Teacher Award and the Student American Veterinary Medical Association National Teaching Award in Basic Science.

Morey Kraus ‘91 is currently the Chief Scientific Officer of the Specialty Diagnostics division of PerkinElmer, Inc. Prior to assuming this role Kraus was the founder and Chief Technology Officer of the ViaCord business unit. ViaCord is a private cord blood banking facility that allows expectant families the opportunity to preserve their baby’s umbilical cord blood for potential medical use by the child or a related family member. Umbilical cord blood stem cells have been used successfully to treat over 70 life-threatening diseases. In line with their mission to increase the value of cord blood to families, Kraus’ team at the ViaCord Research Institute (VRI) is researching the potential of cord blood stem cells to treat many more serious diseases. VRI’s five key areas of research include cord blood technologies, emerging stem cell therapies, genetic screening, therapeutic development and related transplants. Kraus has published six articles in various peer-reviewed journals on topics ranging from the expansion of umbilical cord blood stem cells for clinical use to the in vivo homing of uncultured and selectively amplified cord blood stem cells. In addition, he is the inventor or co-inventor on seven issued patents. Kraus now serves as Chairman of the Medical Scientific Advisory Board at ViaCord Research Institute in addition to his role as Chief Scientific Officer of the Specialty Diagnostics division of PerkinElmer, Inc. Prior to his work at ViaCord, he was the founder, chairman and chief executive officer of t. Breeders, a cellular therapy company focused on stem cell expansion technologies for clinical transplantation. Kraus was a Ph.D. candidate at Worcester Polytechnic Institute in an interdisciplinary Bioprocess Engineering Program combining chemical engineering and biology. He holds a B.A. in comparative religion from American University in Washington, D.C.

David LaPré ’74 has assumed a newly established role as the Global Head of Operations for Roche Diagnostics. Mr. LaPré reports directly to Daniel O'Day, COO Roche Diagnostics and serves on the newly formed Roche Diagnostics Leadership Team as well as the Division’s Product Portfolio Committee. His responsibilities include all manufacturing, supply chain and direct procurement activities across the Division. This newly established global organization brings together more than 4,500 employees in 11 instrument and reagent manufacturing facilities and 2 distribution hubs with a common and integrated focus on operational excellence. Mr. LaPré was appointed Head of Operations for Roche Molecular Diagnostics in November 2009. Throughout his career, Mr. LaPré held positions of increasing responsibility in operations and supply chain management. He spent 12 years in Roche's Pharmaceutical Division starting in 1997 as Vice President of Materials Management in Nutley, New Jersey. In early 2004, he transferred to Basel as Head of the Supply Chain Transformation Program and was appointed Head of Global Supply Chain Management in 2007. He returned to Nutley in 2009 as Vice President, Technical Operations. In recent years Mr. LaPré has also been called on to lead the Tamiflu® pandemic supply task force and the Roche-Genentech integration project. Mr. Lapré's experience prior to Roche includes general management and supply chain positions at Proctor & Gamble and other consumer packaged goods companies. He has an MBA from New York University and a Bachelor of Science degree in Engineering and Life Science from Worcester Polytechnic Institute.

Bruce D. Minsky, MD ‘77 is Professor and Director of Clinical Research in the Department of Radiation Oncology at the MD Anderson Cancer Center. Dr. Minsky received his medical degree from the University of Massachusetts. He completed an internship at New England Deaconess Hospital, and a residency in radiation therapy at Harvard Joint Center for Radiation Therapy. He spent 20 years at Memorial Sloan Kettering Cancer Center and was the Vice Chairman of Radiation Oncology. He moved to the University of Chicago in 1997 and served as a Professor of Radiation and Cellular Oncology and Associate Dean. In 2004, Dr. Minsky received a medical degree honoris causa from Friedrich Alexander University, Erlangen, Germany in recognition for his work in gastrointestinal cancers. Dr. Minsky is an editorial board member of several journals and has served on the board of directors of the American Society of Clinical Oncology and the American Society for Therapeutic Radiology and Oncology Board of Directors.

Joseph P. Morgan, Jr. ’83 was appointed President and Chief Executive Officer of Standard Register in January 2009. He was also elected to a seat on SR’s Board of Directors. Morgan is responsible for championing the growth of the company as an industry-leading document services provider. Prior to serving as acting CEO from September 2008, Morgan served as Executive Vice President and Chief Operating Officer, from April to September 2008, with responsibility for driving execution on operational strategy and ensuring achievement of growth targets through SR’s direct and alternative sales channels. Previously Morgan held the role of managing Standard Register’s On Demand Solutions Group, in addition to serving as Chief Technology Officer for the company. He became CTO in 2003. He began with SR as President and Chief Executive Officer of SMARTworks in 2001. Prior to joining SMARTworks, he served as President of, where he led the creation of an online logistic management solution. Morgan previously served as President and Chairman of the Board of Sony Chemical Corporation of America, where he led the company through the start-up and development of its first integrated manufacturing operation outside of Japan. He has also served in an executive position with FLEXcon, a manufacturer of pressure-sensitive film products and labeling materials. Morgan holds a bachelor’s degree in chemistry from the College of the Holy Cross in Worcester, Mass., a bachelor’s in chemical engineering from Worcester Polytechnic Institute, and an MBA from Clark University in Worcester.

James T. Orcutt ’79 joined New Brunswick Scientific (a NASDAQ-listed company until 2007) in May 2000 as President of the Life Science division and served in that capacity until his appointment as President in 2001. He was further appointed Chief Operating Officer in 2004 and was subsequently named Chief Executive Officer in January 2007. From 2007 until 2009 he was Chairman of the Laboratory Products Association. Mr. Orcutt currently serves on the Boards of Directors for Eppendorf China, Thailand, and India, as well as the New Brunswick Scientific Board. Prior to joining the company, Mr. Orcutt spent five years as Senior Vice President of Sales, Marketing, and Development at Boekel Industries. He previously served for twelve years with Barnstead/Thermolyne (now part of Thermo Fisher Scientific) in various sales and marketing management positions. He holds a Bachelor of Science degree in Chemical Engineering from WPI.

Kevin O’Sullivan is the President and CEO of Massachusetts Biomedical Initiatives, a private economic development organization that promotes the growth and expansion of the Biotechnology, Medical Device and Bioinformatics industry. MBI operates three life science incubator facilities in Worcester - located at Biotech Three, Gateway Park, and Barber Avenue, home to twenty-two companies and over 100 employees, providing cost effective laboratory space and high quality business development services. He previously served as Vice President and Director of Marketing at the Worcester Regional Chamber of Commerce and the City of Worcester where he developed and implemented a comprehensive marketing plan and was charged with the opening of the new Convention Center at the DCU center. From 1986 to 1994 he was a member of the Massachusetts House of Representatives. While a member, he chaired the Committee on Redistricting, was Vice Chair of Ethics, and sat on the Ways and Means Committee. While in the Legislature he championed the Biomedical industry and was a co-sponsor in enacting the Emerging Technology Fund, Investment Tax Credit, and Tax Increment Financing legislation. He was also the former Co-Founder and Chair of the Central Mass Legislative Caucus. He served on the Worcester Business Development Corporation and was part of the development team which created the highly successful one million square foot Massachusetts Biotechnology Research Park. He is the current Chair of the City of Worcester’s License Commission and a member of the Fallon Clinic Board of Trustees. Kevin, who lives in Worcester with his wife Linda and two children, Kylle and Trevor, is also active in many civic and community activities.

Cathy Prescott, DPhil is the Founder Director of Biolatris Ltd., Co-founder and Director of UniverCELL Market Ltd., Chair of the UK National Stem Cell Network Advisory Committee, Director of the East of England Stem Cell Network, Advisory Committee member of The Genome Analysis Centre and Advisory Committee member of the Institute of Pharmaceutical Innovation. She brings over 20 years of experience in research, management and business within the life-science and venture capital sectors. Dr. Prescott is experienced in technology assessment, business development, strategic planning, raising venture funds and private investment. She is also a mentor, assessor and supervisor to the MBA and MBE degree courses at Cambridge University. Prior to Biolatris, Dr. Prescott gained seven years’ experience working as a Director for the venture capital firm Avlar BioVentures and as a Non-Executive Director to several portfolio companies. She was formerly Head of Drug Discovery RiboTargets Ltd and Assistant Director at SmithKline Beecham. Dr. Prescott held post-doctoral fellowships at Max Delbrück Centre for Molecular Medicine (Berlin), Max Planck Institute for Molecular Genetics (Berlin), and Brown University (USA). She holds a DPhil in molecular genetics from the University of Oxford.

Richard Resnick ‘98 CEO GenomeQuest, Inc. Resnick has played a leadership role at GenomeQuest since 2008. He has extensive experience building and growing innovative technology companies in the life sciences and beyond. He was previously CEO of Harmony Line, Inc., an MIT Media Lab company, where he partnered with the famous composer/technologist Tod Machover to develop and commercialize Hyperscore, a unique software tool to enable anyone to compose music. Prior to Harmony Line, Resnick was the CEO of Mosaic Bioinformatics which he sold to NetGenics in 2000. Resnick was the global bioinformatics software head for Wyeth Pharmaceuticals, and got his start in genomics working on the Human Genome Project under Eric Lander at the MIT Whitehead Institute, authoring software applications like Primer3, still widely in use some 20 years later. Resnick frequently gives talks to the public on the implications of cheap genome sequencing. Resnick holds an M.B.A. from the MIT Sloan School of Manangement, an M.S. in Computer Science from Worcester Polytechnic Institute, and a B.S in Computer Science from the University of Massachusetts at Amherst.

  • Email a Friend
  • Bookmark this Page
  • Share this Page